Subbu Nambi
Stock Analyst at Guggenheim
(3.50)
# 797
Out of 4,996 analysts
45
Total ratings
54.05%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintains: Buy | $80 → $95 | $78.48 | +21.05% | 4 | Sep 26, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $67 | $60.03 | +11.61% | 6 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $32 → $36 | $29.19 | +23.33% | 2 | Aug 13, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $184.84 | +35.25% | 2 | Jul 23, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $88 → $115 | $117.21 | -1.89% | 1 | Jun 30, 2025 | |
| NEOG Neogen | Maintains: Buy | $13 → $10 | $5.67 | +76.37% | 3 | Jun 30, 2025 | |
| ILMN Illumina | Maintains: Buy | $122 → $114 | $91.69 | +24.33% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $26.91 | +85.80% | 2 | May 6, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $9.20 | +8.70% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $53.57 | +12.00% | 2 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.70 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $37 | $33.44 | +10.65% | 3 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $31.04 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $162.97 | +22.72% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $49.86 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $4.13 | +45.28% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.83 | +625.69% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.72 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $125.61 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $22.71 | +10.08% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.21 | - | 1 | Dec 14, 2023 |
Tempus AI
Sep 26, 2025
Maintains: Buy
Price Target: $80 → $95
Current: $78.48
Upside: +21.05%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $56 → $67
Current: $60.03
Upside: +11.61%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $29.19
Upside: +23.33%
Danaher
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $184.84
Upside: +35.25%
GeneDx Holdings
Jun 30, 2025
Maintains: Buy
Price Target: $88 → $115
Current: $117.21
Upside: -1.89%
Neogen
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.67
Upside: +76.37%
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $91.69
Upside: +24.33%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $26.91
Upside: +85.80%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $9.20
Upside: +8.70%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $53.57
Upside: +12.00%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.70
Upside: -
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $33.44
Upside: +10.65%
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $31.04
Upside: -
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $162.97
Upside: +22.72%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $49.86
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $4.13
Upside: +45.28%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.83
Upside: +625.69%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $11.72
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $125.61
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $22.71
Upside: +10.08%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.21
Upside: -